The Institute of Cancer Research, London, works closely with a number of funding organisations, including Cancer Research UK, Breast Cancer Now and the Wellcome Trust. We also have a close partnership ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...

Image: A scanning electron microscope image of a prostate cancer cell. Credit: Anne Weston, Francis Crick Institute. CC BY-NC 4.0. At The Institute of Cancer Research, London, we often refer to ...

Scientists have created the most comprehensive map to date of the genetic mutations that fuel cancer – opening the door to extending precision treatments to thousands more patients and offering clues ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...

A powerful new drug for advanced breast cancer can be used to treat emerging tumours, months before they have a chance to grow, helping to keep patients well for longer and delaying the need for later ...

There are many benefits to exercise, including reducing a person’s risk of cancer. Being physically active can also be helpful for many people during and after cancer treatment. Laura-Maria Horga ...

A new AI test can pick out which men with high-risk prostate cancer that has not spread will require life-extending drug abiraterone. Scientists from The Institute of Cancer Research, London, and ...

These days, in the era of personalised medicine, whenever researchers discover a new cancer drug they are expected to show exactly how it works and to prove that it is exerting its therapeutic effect ...

Major trial results presented at the American Society for Clinical Oncology (ASCO) 2025 meeting have confirmed the potential of Roche's drug inavolisib in patients with breast cancer. Read on for the ...

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delay the need for further chemotherapy, new research has shown. The international study, funded by ...